ATSE:VIDAVO

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Market Cap

€4.2m

Last Updated

2021/07/29 21:39 UTC

Data Sources

Company Financials

Executive Summary

Vidavo S.A. designs, develops, and provides connected health, wellness, and healthy ageing solutions. More Details


Snowflake Analysis

Flawless balance sheet and slightly overvalued.

Share Price & News

How has Vidavo's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: VIDAVO is more volatile than 75% of Greek stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: VIDAVO's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Greek stocks.


Market Performance


7 Day Return

29.8%

VIDAVO

1.4%

GR Healthcare Services

2.2%

GR Market


1 Year Return

41.4%

VIDAVO

16.7%

GR Healthcare Services

-15.1%

GR Market

Return vs Industry: VIDAVO exceeded the Greek Healthcare Services industry which returned 13.6% over the past year.

Return vs Market: VIDAVO exceeded the Greek Market which returned -15.9% over the past year.


Shareholder returns

VIDAVOIndustryMarket
7 Day29.8%1.4%2.2%
30 Day-6.1%2.9%-1.1%
90 Day-0.9%-1.3%-3.3%
1 Year41.4%41.4%17.6%16.7%-13.6%-15.1%
3 Year36.4%36.4%49.4%45.1%-47.5%-49.4%
5 Year36.7%36.7%93.4%81.7%-40.0%-43.1%

Long-Term Price Volatility Vs. Market

How volatile is Vidavo's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Vidavo undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: VIDAVO (€5.4) is trading below our estimate of fair value (€19.03)

Significantly Below Fair Value: VIDAVO is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: VIDAVO is poor value based on its PE Ratio (50x) compared to the European Healthcare Services industry average (46.2x).

PE vs Market: VIDAVO is poor value based on its PE Ratio (50x) compared to the Greek market (21.7x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate VIDAVO's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: VIDAVO is overvalued based on its PB Ratio (6.8x) compared to the XE Healthcare Services industry average (4.7x).


Future Growth

How is Vidavo forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

27.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Vidavo has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Vidavo performed over the past 5 years?

11.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: VIDAVO has high quality earnings.

Growing Profit Margin: VIDAVO's current net profit margins (29.7%) are lower than last year (36.3%).


Past Earnings Growth Analysis

Earnings Trend: VIDAVO has become profitable over the past 5 years, growing earnings by 11.7% per year.

Accelerating Growth: VIDAVO's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: VIDAVO had negative earnings growth (-9%) over the past year, making it difficult to compare to the Healthcare Services industry average (24%).


Return on Equity

High ROE: VIDAVO's Return on Equity (13.5%) is considered low.


Financial Health

How is Vidavo's financial position?


Financial Position Analysis

Short Term Liabilities: VIDAVO's short term assets (€1.3M) exceed its short term liabilities (€745.9K).

Long Term Liabilities: VIDAVO's short term assets (€1.3M) exceed its long term liabilities (€118.4K).


Debt to Equity History and Analysis

Debt Level: VIDAVO is debt free.

Reducing Debt: VIDAVO has not had any debt for past 5 years.

Debt Coverage: VIDAVO has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: VIDAVO has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Vidavo current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate VIDAVO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate VIDAVO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if VIDAVO's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VIDAVO's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: VIDAVO is not paying a notable dividend for the Greek market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of VIDAVO's dividend in 3 years as they are not forecast to pay a notable one for the Greek market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Pantelis Aggelidis

no data

Tenure

Mr. Pantelis A. Aggelidis serves as the Chairman and Chief Executive Officer of Vidavo S.A.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Vidavo S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Vidavo S.A.
  • Ticker: VIDAVO
  • Exchange: ATSE
  • Founded: 2002
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: €4.235m
  • Shares outstanding: 857.21k
  • Website: https://www.vidavo.eu

Number of Employees


Location

  • Vidavo S.A.
  • Building D
  • Balkan Center
  • Thessaloniki
  • 570 01
  • Greece

Listings


Biography

Vidavo S.A. designs, develops, and provides connected health, wellness, and healthy ageing solutions. The company offers Vida24, a cloud based platform and customizable app that synchs multi-source data. I...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/07/29 21:39
End of Day Share Price2021/07/29 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.